- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05910216
Online Dance Versus Therapeutic Exercise for Parkinson Disease.
November 25, 2025 updated by: Aline de Souza Pagnussat, Federal University of Health Science of Porto Alegre
Online Dance Versus Online Therapeutic Exercise on Quality of Life - A Protocol for a Randomized Controlled Trial Investigating Social Telerehabilitation Efficacy in Parkinson's Disease.
This is a randomized clinical trial in an online format, which will only include people with PD randomly divided into two groups:
Group 1 - Social Telerehabilitation with Dance and Music Group 2 - Social Telerehabilitation with Multimodal Therapeutic Exercise and Music
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90050-170
- Aline
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Clinical diagnosis of idiopathic PD according to the clinical criteria of the London Brain Bank Criteria (2006);
- Age between 40-90 years;
- A minimum score of 18 in the Montreal Cognitive Assessment;
- Drug therapy/exercise stable for at least four weeks before the study starts;
- Agreement to participate in the study according to the Informed Consent Form.
Exclusion Criteria:
- Auditory and/or visual disturbances that compromise understanding simple commands;
- Access to the internet and a device to access online classes;
- A house member and/or caregiver at home for supervision during the entire experiment, including evaluations and interventions. For patients scoring less than 2.5 points on the modified Hoehn and Yahr Scale (indicating mild disease impairment, independence in daily living activities, and no risk of falls), the requirement for household member supervision may be waived.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group Dance & Music (Online)
Social Telerehabilitation with Dance & Music (Online): The dance intervention will be instructed by a physiotherapist and dance professional, who will follow a structure based on the materials of the Dance for Parkinson's (USA) ® method
|
This is a social telerehabilitation with dance and music.
It will include artistic form, imageries using scenic arts, imageries using aspects of theater and storytelling, movement improvisation, choreography and sequence of movements, complex dance movements, fluidity of movement or connection between one movement and another, rhythmicity and/or movement built with music.
It will include instructions for motor learning, music, and socialization
|
|
Active Comparator: Group Multimodal Therapeutic Exercise & Music (Online)
Social Telerehabilitation with Multimodal Therapeutic Exercise & Music (Online): The intervention with multimodal therapeutic exercise will be instructed by a physiotherapist, who will follow a structure based on a previous study and Physical Therapy Guidelines for People with PD
|
This is a social telerehabilitation with multimodal therapeutic Exercise and Music.
It is restricted to the execution of movements within series and standardized and fixed repetitions, with a background music.
It will not include dance.
It will include instructions for motor learning, music, and socialization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Quality of life
Time Frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
Quality of life measured by Parkinson's Disease Questionnaire (PDQ-39).
Scores range from 0-100 (100 = maximum level of problems).
|
Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
|
Assessment of Well-being
Time Frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
Well-being measured by the scale Positive and Negative Affect Scale (PANAS).
scores range from 10 - 50, a higher score indicates more of a positive affect.
|
Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Motor symptoms severity
Time Frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
Motor symptoms severity measured by the scale Unified Parkinson's disease rating scale, motor subscale (UPDRS III).
Part III: Motor examination: 18 items.
Score range: 0-132, 32 and below is mild, 59 and above is severe.
|
Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
|
|
Assessment of Functional lower extremity strength
Time Frame: Change from Pre to Post treatment (12 weeks)
|
Functional lower extremity strength measured by the Five times sit to stand test (FTSTS).
The time to complete the test is measured, where lower time to perform sit to stand represents better functional lower extremity strength
|
Change from Pre to Post treatment (12 weeks)
|
|
Assessment of Symptoms of Anxiety
Time Frame: Change from Pre to Post treatment (12 weeks)
|
Symptoms of Anxiety measured by the Parkinson Anxiety Scale (PAS).
Scores range from 0-48 (48= maximum level of problems).
|
Change from Pre to Post treatment (12 weeks)
|
|
Assessment of Attention and Memory Recognition
Time Frame: Change from Pre to Post treatment (12 weeks)
|
Executive function by means attention and memory recognition measureb by Online Attention Test (OAT) and Recognition Memory Test (RMT).
|
Change from Pre to Post treatment (12 weeks)
|
|
Feasibility (self-perceptions)
Time Frame: Change from Pre to Post treatment (12 weeks)
|
Self-perceptions (feasibility) of technology usability, socialization and benefits of interventions based on a structured interview.
|
Change from Pre to Post treatment (12 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Aline Pagnussat, PhD, Federal University of Health Science of Porto Alegre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 16, 2023
Primary Completion (Actual)
May 30, 2024
Study Completion (Actual)
June 30, 2024
Study Registration Dates
First Submitted
May 25, 2023
First Submitted That Met QC Criteria
June 15, 2023
First Posted (Actual)
June 18, 2023
Study Record Updates
Last Update Posted (Estimated)
December 3, 2025
Last Update Submitted That Met QC Criteria
November 25, 2025
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ONLINEREHABPD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Dance & Music (Online)
-
Ohio State UniversityCompletedDementia | Dementia With Lewy BodiesUnited States
-
Ankara UniversityCompletedLabor Pain | Fear of ChildbirthTurkey
-
Taipei Medical University Shuang Ho HospitalRecruitingOlder Adults | Cognitive Impairment, MildTaiwan
-
York UniversityCompletedCognitive Change
-
Edge Hill UniversityCompletedDementiaUnited Kingdom
-
Virginia Polytechnic Institute and State UniversityCompleted
-
North Essex Partnership NHS Foundation TrustUniversity College, London; West Essex Clinical Commissioning Group; School for...CompletedStroke | Diabetes Mellitus | Dementia | Mild Cognitive Impairment | Cardiac DiseasesUnited Kingdom
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; University of Ottawa; Université de MontréalUnknownPain | Juvenile Idiopathic ArthritisCanada
-
DanceStream ProjectsAlzheimer's AssociationRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Lewy Body Disease | Frontotemporal Dementia | Vascular DementiaUnited States
-
Istanbul UniversityEnrolling by invitationPhysical Activity | Familial Mediterranean Fever | ExerciseTurkey